Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

MustGrow Biologics Corp. (MGROF)

Compare
0.6600
0.0000
(0.00%)
At close: April 9 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,991.3820
4,712.2000
6.4790
12.8690
--
Operating Expense
5,391.7430
5,517.1880
5,691.6020
3,025.3690
3,369.2480
Operating Income
-404.1020
-804.9880
-5,685.1230
-3,012.5000
-3,369.2480
Net Non Operating Interest Income Expense
221.0990
211.5980
93.4810
-49.4430
-45.8720
Other Income Expense
-62.0260
-83.5500
25.8010
-1.9320
105.1940
Pretax Income
-245.0290
-676.9400
-5,565.8410
-3,063.8750
-3,309.9260
Net Income Common Stockholders
-245.0290
-676.9400
-5,565.8410
-3,063.8750
-3,309.9260
Diluted NI Available to Com Stockholders
-245.0290
-676.9400
-5,565.8410
-3,063.8750
-3,309.9260
Basic EPS
0.00
-0.01
-0.11
-0.07
-0.09
Diluted EPS
0.00
-0.01
-0.11
-0.07
-0.09
Basic Average Shares
51,266.4230
49,894.6400
49,010.2640
43,736.1960
37,311.2780
Diluted Average Shares
51,266.4230
49,894.6400
49,010.2640
43,736.1960
37,311.2780
Total Expenses
5,395.4840
5,517.1880
5,691.6020
3,025.3690
3,369.2480
Net Income from Continuing & Discontinued Operation
-245.0290
-676.9400
-5,565.8410
-3,063.8750
-3,309.9260
Normalized Income
-183.0030
-593.3900
-5,591.6420
-3,061.9430
-3,415.1200
Interest Income
221.0990
211.5980
103.5470
3.3220
--
Interest Expense
--
--
10.0660
52.7650
45.8720
Net Interest Income
221.0990
211.5980
93.4810
-49.4430
-45.8720
EBIT
-276.0540
-676.9400
-5,555.7750
-3,011.1100
-3,264.0540
EBITDA
-276.0540
-676.9400
-5,555.7750
-3,011.1100
-3,264.0540
Net Income from Continuing Operation Net Minority Interest
-245.0290
-676.9400
-5,565.8410
-3,063.8750
-3,309.9260
Total Unusual Items Excluding Goodwill
-62.0260
-83.5500
25.8010
-1.9320
105.1940
Total Unusual Items
-62.0260
-83.5500
25.8010
-1.9320
105.1940
Normalized EBITDA
-214.0280
-593.3900
-5,581.5760
-3,009.1780
-3,369.2480
12/31/2020 - 11/21/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers